Search clinical trials for: Non-muscle invasive bladder cancer
Total 93691 results
-
Genentech, Inc.CompletedNon-Small-Cell Lung Carcinoma | Neoplasm Recurrence, LocalUnited States
-
University of VirginiaCompleted
-
University of VirginiaNational Cancer Institute (NCI)Terminated
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Terminated
-
Tyco Healthcare GroupUnknownObesity-Hypoventilation Syndrome (OHS)France
-
National Center for Complementary and Integrative...Completed
-
National Center for Complementary and Integrative...CompletedUterine Neoplasms | Endometriosis | Ovarian Neoplasms | Pelvic PainUnited States
-
AstraZenecaCompletedProstate CancerTurkey
-
AstraZenecaCompletedInoperable or Recurrent Rectal CancerTurkey
-
National Center for Complementary and Integrative...Completed
-
National Center for Complementary and Integrative...CompletedNausea | Vomiting | ChemotherapyUnited States, Puerto Rico
-
National Center for Complementary and Integrative...Completed
-
Erimos PharmaceuticalsCompleted
-
NovartisProcter and GambleCompletedUrinary IncontinenceUnited States
-
Heidelberg Pharma AGUnited States Department of DefenseCompletedAdvanced MalignanciesUnited States
-
NovartisCompletedOveractive Bladder SyndromeUnited States
-
Oncothyreon Canada Inc.CompletedBreast NeoplasmsUnited States
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompleted
-
Kaunas University of MedicineUnknownPrimary Rectal CancerLithuania
-
National Center for Complementary and Integrative...CompletedUterine Neoplasms | LeiomyomaUnited States
-
NovartisCompletedOveractive Bladder SyndromeUnited States
-
Brooke Army Medical CenterUnknownShock | Hypovolemia | Hypervolemia
-
MedImmune LLCCompletedMelanoma | Malignant Metastatic MelanomaUnited States
-
Spectrum Pharmaceuticals, IncCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
NovartisProcter and GambleCompletedOveractive Bladder (OAB)United States
-
TelikCompletedStudy of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerNon Small Cell Lung CarcinomaUnited States, Australia, Brazil, Chile, Germany, Argentina, Italy, United Kingdom
-
NovartisProcter and GambleCompleted
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompleted
-
MedImmune LLCCompletedProstate CancerUnited States, Belgium, Israel, Russian Federation, Canada, Hungary, Poland
-
Seoul National University HospitalUnknownCervical CancerKorea, Republic of
-
Peking UniversityFudan University; Capital Medical UniversityUnknownStomach Neoplasms | Gastric CancerChina
-
Seoul National University HospitalUnknownCervical CancerKorea, Republic of
-
Hospital of NavarraDr. Enrique Martínez LópezUnknownCarcinoma, Non-Small-Cell LungSpain
-
University of Michigan Rogel Cancer CenterHoffmann-La RocheTerminated
-
University of Michigan Rogel Cancer CenterEli Lilly and CompanyTerminatedCarcinoma of Unknown PrimaryUnited States
-
University of Michigan Rogel Cancer CenterTerminatedLymphoma, Non-Hodgkin'sUnited States
-
University of MilanFondazione Humanitas per la RicercaCompleted
-
National Cancer Center, KoreaUnknownStomach NeoplasmsKorea, Republic of
-
National Cancer Center, KoreaUnknownStomach NeoplasmsKorea, Republic of
-
Aptose Biosciences Inc.University of Chicago; Wake Forest UniversityCompletedCarcinoma, Renal Cell | Metastases, NeoplasmUnited States
-
National Cancer Center, KoreaUnknownStomach NeoplasmsKorea, Republic of
-
NSABP Foundation IncAmgenWithdrawn
-
Aptose Biosciences Inc.Completed
-
Herlev HospitalTerminated
-
Celtic Pharma Development ServicesNeurobiological TechnologiesWithdrawnBrain Tumor | Brain EdemaUnited States, Canada
-
Massachusetts General HospitalEli Lilly and Company; GlaxoSmithKlineCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.CompletedCandidemia | Invasive CandidiasisTaiwan
-
University of California, DavisCompleted